FDA Approves AstraZeneca's Imfinzi For Limited-Stage Small Cell Lung Cancer

RTTNews29minutes ago

Clever Culture Systems Wins Second Major Order From AstraZeneca for APAS Independence Instruments

Small Caps19:35 ET

AstraZeneca Orders 4 More Microbiological Scanners From Clever Culture Systems for $3M

The Market Herald18:33 ET

Top Gap Ups and Downs on Wednesday: CRM, NOW, AZN and More

Moomoo News18:00 ET · Markets

Express News | FDA Approves Durvalumab For Limited-Stage Small Cell Lung Cancer; Recommended Durvalumab Dose Is 1,500 MG Every 4 Weeks For Patients With A Body Weight Of ≥30 KG; Approved Astrazeneca's Imfinzi For Adults With LS-SCLC Whose Disease Has Not Progressed...

Benzinga17:43 ET

AstraZeneca Appoints Iskra Reic as Executive Vice President, International

TipRanks13:45 ET